Black Diamond Therapeutics BDTX
NASDAQ BDTX
$1.88 -0.20 (-9.86%)
As of: Oct 23, 2026 · 3:36 PM EDT

Black Diamond Therapeutics (BDTX) Net Preferred Shares Issued and Repurchased (2019)

Updated

Analysis

Black Diamond Therapeutics (BDTX) Net Preferred Shares Issued and Repurchased (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,130.49 Bn 1,099.07 Bn 19.71 Bn -
2 Johnson & Johnson 635.65 Bn 555.51 Bn 17.30 Bn -
3 AbbVie 505.44 Bn 478.55 Bn 12.70 Bn -
4 Merck 358.27 Bn 312.65 Bn 12.21 Bn -
5 Novartis Ag 291.57 Bn 255.56 Bn 11.24 Bn -
6 Astrazeneca 265.15 Bn 238.84 Bn 12.86 Bn -
7 Amgen 237.41 Bn 192.81 Bn 7.24 Bn -
8 Gilead Sciences 195.01 Bn 169.21 Bn 6.22 Bn -
9 Pfizer 171.23 Bn 117.87 Bn 10.94 Bn -
10 Black Diamond Therapeutics 106.99 Mn -385.93 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 84.83 Mn
API Access

Black Diamond Therapeutics Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=BDTX&period=max&api_key=YOUR_API_KEY